Clinical Trials Directory

Trials / Unknown

UnknownNCT02240342

Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve

Ovarian Rejuvenation: Regeneration of Ovarian Follicles in Women With Poor Ovarian Reserve by Autologous Transplantation of Bone Marrow Derived Progenitors Cells in Peripheral Blood. Pilot Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Hospital Universitario La Fe · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Women delay maternity and, as a consequence, available oocyte number and their quality decrease (9-18% of all IVF patients). Different treatment protocols have been developed nevertheless none of them optimal: the number of oocytes retrieved depends on the present ones. New generation of oocytes and follicles has been defended by some authors and bone marrow seems to be involved. What seems crucial is the niche that produces paracrine signals able to activate dormant cells and to attract undifferentiated cells from other tissues (homing). This phenomenon has been described by our group in other human reproductive tissues like endometrium. The purpose of the study is to improve ovarian reserve in unfertile women with poor ovarian reserve by means of bone marrow protective capacity. Bone marrow progenitor cells will be delivered into the ovarian artery allowing them to colonize ovarian niche. The study hypothesis is that bone marrow progenitor cells will improve ovarian reserve differentiating themselves into germ cells or, more likely, stimulating the niche to activate dormant follicles.

Conditions

Interventions

TypeNameDescription
DRUGBone marrow transplant into ovarian arteryBone marrow progenitors mobilized to peripheral blood, obtained by plasmapheresis and infused into the ovarian artery

Timeline

Start date
2014-09-01
Primary completion
2015-03-01
Completion
2016-03-01
First posted
2014-09-15
Last updated
2014-09-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02240342. Inclusion in this directory is not an endorsement.